Article
The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jun 2007
Abraham Robert T, Gibbons James J
Abstract excerpt
The immunosuppressive drug rapamycin played a key role in the functional characterization of mammalian target of rapamycin (mTOR), an unusual protein kinase that coordinates growth factor and nutrient availability with cell growth and proliferation. Several rapamycin-related compounds are now in various stages of clinical development as anticancer agents. This article highlights recent advances in our...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
